TAO Synergies (TAOX) Research & Development (2019 - 2026)

TAO Synergies (TAOX) has reported Research & Development for 8 consecutive years, with $31855.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development fell 78.56% year-over-year to $31855.0; the trailing twelve-month figure through Jun 2026 stood at $173309.0 (down 79.77% YoY), and the FY2025 full-year result was $322225.0, down 79.84% from the prior year.
• Research & Development rose to $31855.0 in Q2 2026 per TAOX's latest filing, from $28600.0 in the prior quarter.
• Across five years, Research & Development topped out at $1.9 million in Q2 2022 and bottomed at $28600.0 in Q1 2026.
• Historically, Research & Development has averaged $571180.8 across 5 years, with a median of $324639.5 in 2023.
• The sharpest annual moves came in 2022 and 2025: Research & Development surged 96.81% in 2022, then tumbled 90.02% in 2025.
• Over 5 years, Research & Development stood at $1.4 million in 2022, then slumped by 59.1% to $577893.0 in 2023, then fell by 26.54% to $424508.0 in 2024, then sank by 86.23% to $58466.0 in 2025, then tumbled by 45.52% to $31855.0 in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $31855.0, $28600.0, and $58466.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.